HilleVax, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 26.89 million compared to USD 67.89 million a year ago. Basic loss per share from continuing operations was USD 0.71 compared to USD 10.06 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.13 USD | -3.74% | -5.47% | -18.19% |
05-09 | HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.19% | 648M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023